Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children.

Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of children.

<h4>Background</h4>The diagnosis of autism spectrum disorder (ASD) at the earliest age possible is important for initiating optimally effective intervention. In the United States the average age of diagnosis is 4 years. Identifying metabolic biomarker signatures of ASD from blood samples...

Full description

Bibliographic Details
Main Authors: Paul R West, David G Amaral, Preeti Bais, Alan M Smith, Laura A Egnash, Mark E Ross, Jessica A Palmer, Burr R Fontaine, Kevin R Conard, Blythe A Corbett, Gabriela G Cezar, Elizabeth L R Donley, Robert E Burrier
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0112445

Internet

https://doi.org/10.1371/journal.pone.0112445

Similar Items